BSE filing, NSE: MAXHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹860.00
- Market cap
- ₹83,705 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 57.5×Sector 52.3×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 40.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Management Change
Max Healthcare appointed Dharmender Kumar as Director and Chief - Public Affairs, effective November 1, 2026. The change was approved at the October 30, 2026 board meeting.
Max Healthcare Institute Capacity Expansion: ₹97 Cr Investment
Max Healthcare will add 60 beds through two new floors at its Vaishali hospital. The Rs.97 Crore project is internally funded and due within 24 months.
- Value
- ₹97.00 Cr
- Execution
- Within 24 months
- hospital beds
- 60.0 beds
Max Healthcare Institute Capacity Expansion: ₹93 Cr Investment
Max Healthcare approved adding about 85 beds at its Noida hospital through redevelopment, at a cost of Rs 93 Crore funded by internal accruals. Commissioning is planned within 15 months.
- Value
- ₹93.00 Cr
- Execution
- Within 15 months
- hospital beds
- 85.0 beds
Max Healthcare Institute Results Update
Max Healthcare Q2 FY27 revenue rose to ₹3,219 Cr, up 20% YoY, with PAT at ₹448 Cr. Board approved ₹415 Cr capex for 209 additional beds.
- hospital beds approved for addition
- 209 beds
Max Healthcare Institute Q2 FY27 Results: Net Profit ₹414.4 Cr, Down 15.7% YoY
Max Healthcare Institute Ltd reported revenue from operations of ₹2,569 Cr (+20.3% YoY) and net profit of ₹414.4 Cr (-15.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹414.4 Cr · -15.7% YoY
Max Healthcare Institute Employee Stock Options
Max Healthcare's NRC approved 95,000 ESOPs at ₹800 exercise price under its 2022 scheme. Vesting spans 1-5 years with a 3-year post-vesting exercise window.
Other merger & restructuring announcements
All →Ginni Filaments Merger & Restructuring
Ginni Filaments incorporated a wholly owned subsidiary, Ginni RSA (Pty) Ltd, in South Africa. The subsidiary will trade and distribute wet wipes internationally.
Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr
Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.
- Value
- ₹141.4 Cr
Skipper Merger & Restructuring Worth ₹0.48 Cr
Skipper Limited incorporated a wholly owned subsidiary, Skipper Gridtech Inc, in Texas, USA. The subsidiary's share capital is up to USD 50,000 (about Rs 0.48 Crore).
- Value
- ₹0.48 Cr
Asian Energy Services Merger & Restructuring
Asian Energy Services will participate in incorporating Asian Energy Foundation, a Section 8 non-profit company limited by guarantee, holding 49% control. No cash consideration or share subscription is involved.
Waaree Renewable Technologies Merger & Restructuring
Waaree Renewable completed transferring its entire stake in Waaree Green Data Centers to parent Waaree Energies. The company ceased to be a subsidiary from 30 October 2026.
Goodricke Group Merger & Restructuring Worth ₹5 Cr
Goodricke Group signed a non-binding MoU to sell its Barnesbeg Tea Estate for Rs. 5 Crore. Completion of the definitive sale is expected by January 2027.
- Value
- ₹5.00 Cr